Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-01-13 @ 12:37 AM
Study NCT ID:
NCT00364195
Status:
COMPLETED
Last Update Posted:
2009-01-09
First Post:
2006-08-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer
Sponsor:
YM BioSciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
YMB1002 203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None